Literature DB >> 31782026

Shiga toxin-producing Escherichia coli in household members of children with hemolytic uremic syndrome.

Laura Fernanda Alconcher1, Marta Rivas2, Lucas Ivan Lucarelli3, Jimena Galavotti4, Mabel Rizzo4.   

Abstract

The objective is to establish the frequency of STEC infections in household contacts of HUS patients. We studied 292 household contacts of 82 HUS patients attended from 2010 to 2018. In HUS cases, diagnostic criteria were (1) isolation and characterization of STEC strains, (2) detection of free fecal Shiga toxin (FFStx), and (3) detection of anti-O serogroup-specific antibodies. Contacts were studied by screening of stx genes by polymerase chain reaction and/or STEC isolation from stool samples. Clonal relation of STEC strains was established by pulsed-field gel electrophoresis (PFGE). Frequencies of HUS patients without STEC isolation with STEC-positive contacts were determined. Serotypes and stx-genotypes in patients and contacts were analyzed. Thirty (36.6%) HUS patients had 36 STEC-positive contacts. Fourteen (38.8%) were children, 20 adults, and 2 dogs. One sibling developed HUS, 6 contacts had gastrointestinal symptoms, and the rest were asymptomatic. In 5 of 30 HUS patients, STEC infection could not be confirmed, and 2 cases were diagnosed only by FFStx detection. Of the remaining 23 HUS patients, 16 had E. coli O157 and 7 E. coli O145 infection. Serotype and/or stx-genotype concordance was established in 19 (83%) of 23 HUS patients and their contacts. Five HUS cases and their contacts studied by PFGE showed macrorestriction patterns with more than 90% similarity. Nearly one third of HUS patients had STEC-positive family contacts, and one third of them were children. Early identification is important to prevent ongoing contamination among family and institutional contacts and to facilitate prompt detection of HUS in STEC-positive contacts.

Entities:  

Keywords:  Asymptomatic carriers; HUS; Household; Outbreaks; STEC; Secondary transmission

Mesh:

Substances:

Year:  2019        PMID: 31782026     DOI: 10.1007/s10096-019-03738-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  THE HEMOLYTIC-UREMIC SYNDROME.

Authors:  C GIANANTONIO; M VITACCO; F MENDILAHARZU; A RUTTY; J MENDILAHARZU
Journal:  J Pediatr       Date:  1964-04       Impact factor: 4.406

Review 2.  Risk Factors for Shiga Toxin-Producing Escherichia coli-Associated Human Diseases.

Authors:  Marta Rivas; Isabel Chinen; Elizabeth Miliwebsky; Marcelo Masana
Journal:  Microbiol Spectr       Date:  2014-10

3.  Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina.

Authors:  M Rivas; E Miliwebsky; I Chinen; C D Roldán; L Balbi; B García; G Fiorilli; S Sosa-Estani; J Kincaid; J Rangel; P M Griffin
Journal:  Foodborne Pathog Dis       Date:  2006       Impact factor: 3.171

4.  Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature.

Authors:  Flemming Scheutz; Louise D Teel; Lothar Beutin; Denis Piérard; Glenn Buvens; Helge Karch; Alexander Mellmann; Alfredo Caprioli; Rosangela Tozzoli; Stefano Morabito; Nancy A Strockbine; Angela R Melton-Celsa; Maria Sanchez; Søren Persson; Alison D O'Brien
Journal:  J Clin Microbiol       Date:  2012-07-03       Impact factor: 5.948

Review 5.  Shiga toxin-producing Escherichia coli: an overview.

Authors:  C L Gyles
Journal:  J Anim Sci       Date:  2006-11-03       Impact factor: 3.159

6.  Sporadic STEC O157 infection: secondary household transmission in Wales.

Authors:  S M Parry; R L Salmon
Journal:  Emerg Infect Dis       Date:  1998 Oct-Dec       Impact factor: 6.883

7.  Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection: promptly separating siblings might be the key.

Authors:  Dirk Werber; Brendan W Mason; Meirion R Evans; Roland L Salmon
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

8.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

9.  Prevention of secondary household transmission during Shiga toxin-producing Escherichia coli outbreaks.

Authors:  K Tokuda; Y Yahata; T Sunagawa
Journal:  Epidemiol Infect       Date:  2016-06-13       Impact factor: 4.434

10.  Risk factors for sporadic Shiga toxin-producing Escherichia coli infections in children, Argentina.

Authors:  Marta Rivas; Sergio Sosa-Estani; Josefa Rangel; Maria G Caletti; Patricia Vallés; Carlos D Roldán; Laura Balbi; Maria C Marsano de Mollar; Diego Amoedo; Elizabeth Miliwebsky; Isabel Chinen; Robert M Hoekstra; Paul Mead; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more
  6 in total

1.  Etiological diagnosis of post-diarrheal hemolytic uremic syndrome (HUS): humoral response contribution.

Authors:  Gabriela A Fiorentino; Elizabeth Miliwebsky; María Victoria Ramos; Gisela Zolezzi; Isabel Chinen; Glenda Guzmán; Rubén Nocera; Romina Fernández-Brando; Adriana Santiago; Ramón Exeni; Marina S Palermo
Journal:  Pediatr Nephrol       Date:  2022-07-08       Impact factor: 3.714

2.  Epidemiological investigation of recurrent outbreaks of haemolytic uraemic syndrome caused by Shiga toxin-producing Escherichia coli serotype O55:H7 in England, 2014-2018.

Authors:  C Sawyer; B Vishram; C Jenkins; F Jorgensen; L Byrne; A F W Mikhail; T J Dallman; K Carroll; L Ahyow; Q Vahora; G Godbole; S Balasegaram
Journal:  Epidemiol Infect       Date:  2021-04-19       Impact factor: 2.451

3.  Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome.

Authors:  Romina S Álvarez; Fernando D Gómez; Elsa Zotta; Adrienne W Paton; James C Paton; Cristina Ibarra; Flavia Sacerdoti; María M Amaral
Journal:  Toxins (Basel)       Date:  2021-07-29       Impact factor: 4.546

Review 4.  Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.

Authors:  Izabella de Macedo Henrique; Flavia Sacerdoti; Raissa Lozzardo Ferreira; Camila Henrique; Maria Marta Amaral; Roxane Maria Fontes Piazza; Daniela Luz
Journal:  Front Cell Infect Microbiol       Date:  2022-02-10       Impact factor: 5.293

5.  The Deleterious Effects of Shiga Toxin Type 2 Are Neutralized In Vitro by FabF8:Stx2 Recombinant Monoclonal Antibody.

Authors:  Daniela Luz; Fernando D Gómez; Raíssa L Ferreira; Bruna S Melo; Beatriz E C Guth; Wagner Quintilio; Ana Maria Moro; Agostina Presta; Flavia Sacerdoti; Cristina Ibarra; Gang Chen; Sachdev S Sidhu; María Marta Amaral; Roxane M F Piazza
Journal:  Toxins (Basel)       Date:  2021-11-22       Impact factor: 4.546

6.  Detection of Shiga Toxin-Producing Escherichia coli (STEC) in the Endocervix of Asymptomatic Pregnant Women. Can STEC Be a Risk Factor for Adverse Pregnancy Outcomes?

Authors:  María Luján Scalise; Nicolás Garimano; Marcelo Sanz; Nora Lia Padola; Patricia Leonino; Adriana Pereyra; Roberto Casale; María Marta Amaral; Flavia Sacerdoti; Cristina Ibarra
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-20       Impact factor: 6.055

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.